(1) The year ended December 31, 2023 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share awards ...

CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...

(1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share ...

Core Laboratories Inc. CLB generates revenues by providing specialized services and products to the oil and gas industry. The company offers reservoir optimization, production enhancement and ...

Core Laboratories Inc. CLB has experienced a year-to-date (“YTD”) stock price decrease of 29.7%, significantly underperforming the broader oil and gas sector and the oil and gas field services ...

HOUSTON, Oct. 9, 2023 /PRNewswire/ -- Halliburton Company (NYSE: HAL) and Core Laboratories Inc. (NYSE: CLB) today announced a strategic collaboration in the U.S. to compress the delivery time of ...

Wide-moat Core Laboratories posted third-quarter results mostly in line with our estimates. Revenue of $134 million was up 3% sequentially and 7% year over year, while operating income of $20 million ...

Core Laboratories Inc. (NYSE:CLB) surged by over 13% after the company reported better-than-expected results for its Q2 2025 last week. Uranium stocks posted a massive rally earlier this month ...

Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. US ...

Core Laboratories is in good financial health. At the last reporting period, the firm had $16 million of cash on hand and $180 million of long-term debt. 2022 net debt/adjusted EBITDA was elevated at ...